Patrick Siegrist, MD | Cardiologia | Angiografia coronarica
Emergenza

Emergenza

044 387 37 11

Giorno

numero di emergenza

044 387 21 11

Notte

numero di emergenza

044 387 37 11

Centralino telefonico dell'Hirslanden Heart Center di Zurigo

Dr. med. Patrick Siegrist

CV


2023 - oggi

Membro del Comitato esecutivo


2019 - oggi

Centro del cuore Hirslanden Zurigo Apertura dello studio 01.07.2019


2016 – 2020

Medico senior in cardiologia interventistica, Ospedale Universitario di Zurigo Responsabile interventi complessi PCI/coronarici, spec. programma CTO


2012 – 2016

Fellowship in Invasive Cardiology, Osaka University Graduate School of Medicine, Osaka, Japan

Aprile - giugno 2014 Visiting Invasive Cardiologist, HSC Medical Center, Kuala Lumpur, Malaysia

Apr – Sep 2016 Invasive Cardiologist Suita Tokushukai Hospital, Osaka, Japan


2011

Centro Cuore Hirslanden in funzione OA


2003 – 2010

Residenza e perfezionamento come specialista in cardiologia presso l'ospedale universitario di Zurigo e l'ospedale Zollikerberg


2005

Dottorato / Dissertazione: Dipartimento di Medicina Nucleare, Cardiologia, Ospedale Universitario di Zurigo "Influence of spontaneous and pacemaker-induced left bundle branch block on quantitative regional myocardial blood flow at rest and during adenosine and bicycle-induced hyperemia".


2002

Stage in cardiologia/ematologia Mount Sinai School of Medicine, New York


1997 – 2003

Studio della medicina umana a Zurigo


Studi e diplomi

1984 – 1990 Scuola primaria a Küsnacht, Svizzera

1990 – 1992 Scuola secondaria a Küsnacht, Svizzera

1992 – 1997 Kantonsschule Küsnacht (equivalente del liceo e dell'università)

Jan 1997 Matura Typus D (diploma di scuola superiore con lingue moderne)

Jan 1997 – May 1997 Servizio militare

Jun / Jul 1997 Corso d'inglese presso l'English Language Center di Boston, MA, USA

Oct 1997 – Oct 2003 Scuola di medicina all'Università di Zurigo, Svizzera,

Mar / Apr 2002 Subinternship in Cardiologia ed Ematologia, Mount Sinai School of Medicine, New York, NY, USA

Oct 2003 Laurea in medicina all'Università di Zurigo, Svizzera

Dec 2010 Certificazione del Consiglio (FMH) in Cardiologia, Svizzera

Oct 2011 – Dec 2011 Corso di lingua giapponese alla scuola giapponese KAI di Tokyo

COMPETENZE DI BASE

Esami cardiaci invasivi (angiografia coronarica, cateterizzazione cardiaca)

Terapia interventistica della malattia coronarica (PCI con impianto di stent)

Impianto di valvola aortica (chirurgo TAVI)

Terapia endovascolare dell'aneurisma aortico

ECG, ECG da sforzo, ECG a lungo termine, ecocardiografia

Cura dei pazienti adulti con difetti cardiaci congeniti

LINGUE

Tedesco, Inglese, Francese, Spagnolo, Giapponese

PUBBLICAZIONI


1. Tetrahydrobiopterin restores impaired coronary microvascular dysfunction in hypercholesteremia. Wyss CA, Koepfli P, Namdar M, Siegrist PT, Lüscher TF, Camici PG, P. Kaufmann PA. Eur J Nucl Med Mol Imaging 2005;32(1):84-91. Erratum in: Eur J Nucl Med Mol Imaging 2005;32(3):372

2. The quantification of absolute myocardial perfusion in humans by contrast echocardiography: algorithm and validation. Vogel R, Indermühle A, Reinhardt J, Meier P, Siegrist PT, Namdar M, Kaufmann PA, Seiler C. J Am Coll Cardiol 2005;45(5):754-62

3. Integrated PET/CT for the assessment of coronary artery disease. Namdar M, Hany TF, Koepfli P, Burger C, Wyss CA, Siegrist PT, Luscher TF, von Schulthess GK, Kaufmann PA. J Nucl Med 2005;46(6):930-5

4. Caffeine decreases exercise-induced myocardial flow reserve. Namdar M, Koepfli P, Grathwohl R, Siegrist PT, Klainguti M, Schepis T, Delaloye R, Wyss CA, Fleischmann SP, Gaemperli O, Kaufmann PA. J Am Coll Cardiol 2006;47(2):405-10

5. Repeatability of Cold Pressor Test-Induced Flow Increase Assessed with H215O and PET. Siegrist PT, Gaemperli O, Koepfli P, Schepis T, Namdar M, Valenta I, Aiello F, Fleischmann SP, Alkadhi H, Kaufmann PA. J Nucl Med 2006;47(9):1420-6

6. Assessment of myocardial perfusion by dynamic O-15-labeled water PET imaging: validation of a new fast factor analysis. Adachi I, Gaemperli O, Valenta I, Schepis T, Siegrist PT, Treyer V, Burger C, Morita K, Kaufmann PA. J Nucl Cardiol 2007;14(5):698-705

7. (13)N-ammonia myocardial perfusion imaging with a PET/CT scanner: impact on clinical decision making and cost-effectiveness. Siegrist PT, Husmann L, Knabenhans M, Gaemperli O, Valenta I, Hoefflinghaus T, Scheffel H, Stolzmann P, Alkadhi H, Kaufmann PA. Eur J Nucl Med Mol Imaging 2008;35(5):889-95

8. Diagnostic accuracy of myocardial perfusion imaging with single photon emission computed tomography and positron emission tomography: a comparison with coronary angiography. Husmann L, Wiegand M, Valenta I, Gaemperli O, Schepis T, Siegrist PT, Namdar M, Wyss CA, Alkadhi H, Kaufmann PA. Int J Cardiovasc Imaging 2008;24(5):511-8

9. Interaction of caffeine with regadenoson-induced hyperemic myocardial blood flow as measured by positron emission tomography: a randomized, double-blind, placebo-controlled crossover trial Gaemperli O, Schepis T, Koepfli P, Siegrist PT, Fleischmann S, Nguyen P, Olmsted, Wang W, Lieu H, Kaufmann PA. J Am Coll Cardiol 2008;51(3):328-9

10. Effects of AV delay programming on ventricular resynchronisation: role of radionuclide ventriculography Siegrist PT, Comte N, Holzmeister J, Sütsch G, Koepfli P, Namdar M, Duru F, Brunckhorst C, Scharf C, Kaufmann PA. Eur J Nucl Med Mol Imaging 2008;35(8):1516-22

11. Impact of hypertension on the diagnostic accuracy of coronary angiography with computed tomography. Husmann L, Scheffel H, Valenta I, Schepis T, Gaemperli O, Aepli U, Siegrist PT, Leschka S, Desbiolles L, Stolzmann P, Marincek B, Alkadhi H, Kaufmann PA. Int J Cardiovasc Imaging 2008;24(7):763-70

12. Protocol for measuring myocardial blood flow by PET/CT in cats Jenni SD, Schepis T, Jenni R, Siegrist PT, Kaufmann PA, Glaus TM. Eur J Nucl Med Mol Imaging 2008;36(2):244-9

13. Role of attenuation correction to discriminate defects caused by left bundle branch block versus coronary stenosis in single photon emission computed tomography myocardial perfusion imaging. Hoefflinghaus T, Husmann L, Valenta I, Moonen C, Gaemperli O, Schepis T, Namdar M, Koepfli P, Siegrist PT, Kaufmann PA. Clin Nucl Med 2008;33(11):748-51

14. Caffeine impairs myocardial blood flow response to physical exercise in patients with coronary artery disease as well as in age-matched controls. Namdar M, Schepis T, Koepfli P, Gaemperli O, Siegrist PT, Grathwohl R, Valenta I, Delaloye R, Klainguti M, Wyss CA, Lüscher TF, Kaufmann PA. PLoS One 2009;4(5):e5665

15. Long-term prognostic value of 13N-ammonia myocardial perfusion positron emission tomography added value of coronary flow reserve. Herzog BA, Husmann L, Valenta I, Gaemperli O, Siegrist PT, Tay FM, Burkhard N, Wyss CA, Kaufmann PA. J Am Coll Cardiol 2009;54(2):150-6

16. Left bundle branch block causes relative but not absolute septal underperfusion during exercise. Koepfli P, Wyss CA, Gaemperli O, Siegrist PT, Klainguti M, Schepis T, Namdar M, Bechir M, Hoefflinghaus T, Duru F, Kaufmann PA. Eur Heart J 2009;30(24):2993-9

17. Percutaneous closure of patent foramen ovale and valvular function – effect of the amplatzer occluder Krasniqi N, Roth J, Siegrist PT, Toggweiler S, Gruner C, Greutmann M, Tanner FC, Lüscher TF, Corti R. J Invasive Cardiol 2012;24(6):274-7

18. Outcome of percutaneous patent foramen ovale closure with the Premere occluder – a single center experience Siegrist PT, Enz T, Krasniqi N, Scherff F, Roth J, Tanner F, Corti R, Lüscher TF. J Cardiobiol 2014;2(1): 6

19. Recovery mismatch between myocardial blood flow and cardiac workload after physical exercise. Siegrist PT, Koepfli P, Namdar M, Pazhenkottil AP, Nkoulou R, Lüscher TF, Kaufmann PA. Eur Heart J Cardiovascular Imaging 2014;15(12):1386-90

20. Analysis of admission electrocardiographic patterns in survivors and non-survivors of unprotected left main acute coronary syndrome undergoing percutaneous coronary intervention. Krasniqi N, Horisberger S, Siegrist PT, Fuchs TA, Saguner AM, Scherff F, Eriksson U, Corti R, Lüscher TF. J Cardiobiol 2014;2(2): 5

21. Reproducibility and clinical potential of myocardial mass at risk calculated by a novel software utilizing cardiac computed tomography information. Sumitsuji S, Ide S, Siegrist PT, Salah Youssef, Yokoi K, Yoshida M, Awata M, Yamasaki K, Tachibana K, Kaneda H, Nanto S, Sakata Y. Cardiovasc Interv Ther. 2016;31(3):218-25

22. Right coronary artery motion analysis: a novel method to measure right ventricular systolic function by selective coronary angiography Baumann F, Obeid S, Gilhofer T, Siegrist P, von Spiczak J, Lüscher TF, Binder RK Int J Cardiovasc Imaging. 2019;35:1557-61

23. Association of the body mass index with outcomes in elderly patients (≥80 years) undergoing percutaneous coronary intervention. Leistner DM, Bazara S, Münch C, Steiner J, Erbay A, Siegrist PT, Skurk C, Lauten A. Müller-Werdan U, Landmesser U, Stähli BE. Int J Cardiol. 2019;292:73-77

24. Association of left ventricular end-diastolic pressure with mortality in patients undergoing percutaneous coronary intervention for acute coronary syndromes Leistner DM, Dietrich S, Erbay A, Steiner J, Abdelwahed Y, Siegrist PT, Schindler M, Skurk C, Haghikia A, Sinning D, Riedel M, Landmesser U, Stähli BE Catheter Cardiovasc Interv. 2020;96(4):E439-E446

25. Diagnostic performance of angiography-based quantitative flow ratio for the identification of myocardial ischemia as assessed by 13N-ammonia myocardial perfusion imaging positron emission tomography Strähl M, Schindler M, Keller LS, Holy E, Jakob P, Siegrist PT, Templin C, Maier W, Buechel RR, Kaufmann PA, Gebhard C, Stähli BE Int J Cardiol. 2020;314:13-19

26. Impact of a nationwide COVID-19 lockdown on acute coronary syndrome referrals Holy EW, Jakob P, Manka R, Stähli BE, Siegrist PT, Ruschitzka F, Templin C Cardiol J. 2020;27(5):633-635

27. Outcomes of acute coronary syndromes in coronavirus disease 2019 Cammann VL, Szawan KA, D'Ascenzo F, Gili S, Dreiding S, Würdinger M, Manka R, Stähli BE, Holy EW, Siegrist P, Jakob P, Meyer P, Iannaccone M, Di Simone E, Secco GG, Saccocci M, Bettari L, Ielasi A, Tespili M, Quadri G, Varbella F, Raposeiras-Roubin S, Abu-Assi E, Mancone M, Sardella G, Infusino F, Fedele F, Patti G, Mennuni M, Rognoni A, Bollati M, Olivotti L, Cordone S, Carugo S, Barbieri L, Gaido L, Giammaria M, Gambino A, D'Amico M, Galluzzo A, Ugo F, Trabattoni D, De Filippo O, De Ferrari GM, Vecchione C, Citro R, Ghadri JR, Templin C Clin Res Cardiol. 2020;109(12):1601-1604

Assistente Ilena Budel


Nome

Ilena Budel


Funzione

Assistente di studio medico


E-Mail

praxissiegrist@herzzentrum.ch

Lingue

Tedesco, Inglese, Italiano

Contatti

T 044 387 37 11
F 044 387 22 40
siegrist@herzzentrum.ch